Armata Pharmaceuticals, Inc. (ARMP)

[timberwolf7]

Anti-biotic developers going bankrupt.. link to article

Its why I refuse to pay a 'high price' this far out from potential approval. I would love to have 50,000 shares of this one early on, because at some point, its going to have to start selling its developments and as the article mentions, IF the anti-biotic works, the 'revenue stream' is over for that patient. Companies like this one may have a highly needed product, but once approved, it might struggle to survive financially or recover the costs of the development.

So, again, I refuse to pay much over a $ for a situation like that. Yes it might be a nice return on the 'PR' as the clinical trials move forward, but you have to feel sorry for folks like this. Its not like a cancer treatment, its not like an AD drug that will generate long term revenues or they can afford to demand a high price for while its being used.

Got another one in the cancer treatment world that so far has shown to be somewhat successful. But they are saying, they want to bring to the world, a low cost cancer treatment drug. And their simple product is showing promise and its mechanism of action is very interesting. Yet, no one seems interested in it and I am starting to suspect, its because they are not talking about charging a lot of money for it to be used. No secret, money streams post development is the driver for the bio world.

ARMP from my initial look at it, is likely to face this same challenge, ie, if it works, and the patient is cured, they have to wait for the next 'case'...


https://www.msn.com/en-us/health/medical/crisis-looms-in-antibiotics-as-drug-makers-go-bankrupt/ar-BBYkqcK?li=BBnb7Kz